Viwit Pharmaceutical Co., LTD
|
Sorafenib Tosylate with CAS 475207-59-1 is co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar.
Sorafenib Tosylate (CAS 475207-59-1) is approved in the US for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.
|
The product above are not for sales where the patents are applicable and still valid.
|
Send Inquiry
|
Beijing Hope Pharmaceutical Co., Ltd.
|
Beijing Hope Pharmaceutical Co., Ltd. is a high-tech pharmaceutical company based in China and facing the world. The main business is R&D, production and sales of APIs and APIs, import and export trade, R&D of new pharmaceutical preparations and new drug registration. We have an R&D center in Beijing, a pharmaceutical intermediate production base in Hebei and Zhejiang, and a GMP-certified API production base in Shandong. |
Send Inquiry
|